Uterine cavity vacuum suction device

By designing a uterine pressure suction device, the combination of a rigid suction tube and a hemostatic balloon assembly is solved, and the problem of postpartum uterine bleeding and uterine cavity cleaning is achieved, rapid hemostatic and cleansing effects are achieved, and the life safety of the mother is improved.

WO2024244877A1PCT designated stage expired Publication Date: 2024-12-05HEBEI BEILONG MEDICAL TECHNOLOGY INC
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/090769
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-09
Filing Date
2024-04-30
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

Postpartum uterine bleeding is difficult to control, the prior art cannot use negative pressure suction device and balloon filling to stop bleeding, and the blood and membrane tissue cleaning efficiency in the uterine cavity is low.

Method used

A uterine pressure suction device is designed, including a hard suction tube and hemostatic balloon assembly, which attracts blood and blood clots in the uterus through the negative pressure drainage port, and continuously compresses and stops hemostatic balloons expanded through the injection channel, combined with traction to strengthen the filling of the lower uterus.

Benefits of technology

It realizes rapid and effective uterine cavity cleaning and hemostasis, and can simultaneously control postpartum bleeding and clean up uterine residues, improving the life safety of the mother.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024090769_05122024_PF_FP_ABST
    Figure CN2024090769_05122024_PF_FP_ABST
Patent Text Reader

Abstract

Provided is a uterine cavity vacuum suction device. The uterine cavity vacuum suction device is configured for treating and preventing postpartum uterine bleeding. Components of the uterine cavity vacuum suction device include a hard suction pipe (1) and a hemostatic balloon assembly (2). A drainage cavity (101) is formed in the hard suction pipe (1). A negative-pressure drainage port (1031) communicated with the drainage cavity (101) is formed at one end of the hard suction pipe (1), and the other end of the hard suction pipe (1) is configured for connecting a negative pressure source. A traction part (3) is arranged at the end of the hard suction pipe (1) distal to the negative-pressure drainage port (1031). The hemostatic balloon assembly (2) has a hemostatic balloon (201) fixedly to the hard suction pipe (1) and a liquid injection channel (202) communicated with the hemostatic balloon (201). The uterine cavity vacuum suction device has a plurality of hemostatic functions. The hard suction pipe (1) is configured for absorbing blood, blood clots, residual placenta tissues, and the like in the uterus, and is also configured for continuous vacuum suction to keep a uterine cavity closed so as to achieve hemostasis. The hemostatic balloon (201) expands to compress the bleeding part in the uterus. The traction part (3) is configured for applying an external traction force to help compress the uterus and pelvic blood vessels to quickly stop bleeding.
Need to check novelty before this filing date? Find Prior Art

Description

Uterine suction device

[0001] This disclosure claims priority to a patent application filed with the China Patent Office on May 9, 2023, with application number 202321101904.4 and title “Uterine Intrauterine Suction Device,” the entire contents of which are incorporated herein by reference. Technical Field

[0002] The present disclosure relates to the technical field of medical devices, and in particular to a uterine cavity suction device. Background Art

[0003] Currently, uterine bleeding during childbirth is a serious obstetric complication that greatly affects the life safety of mothers. There are many causes of postpartum uterine bleeding, and they are difficult to identify. Medical staff need to start from multiple links at the same time to control bleeding in the shortest time to save lives. Postpartum bleeding caused by placenta accreta is the most difficult to control because the site of placenta implantation is often located in the lower uterine segment and cervix, which lacks the ability of muscle contraction. In recent years, intrauterine balloon compression has gradually become an alternative solution for treating postpartum hemorrhage. This solution injects water into the balloon to make it continuously expand, thereby compressing the blood vessels at the bleeding site, thereby achieving hemostasis.

[0004] Furthermore, after childbirth, the uterine cavity often contains blood, blood clots, and even fetal membranes that need to be drained. Existing technologies typically use suction devices inserted into the uterine cavity to remove this blood, blood clots, and fetal membranes. If a balloon tamponade is used to stop bleeding, a negative pressure suction device cannot be used simultaneously. Summary of the Invention

[0005] In view of this, the present disclosure aims to propose a uterine suction device that controls postpartum bleeding from multiple aspects, cleans the uterus and applies pressure to the uterine wall simultaneously to achieve rapid hemostasis.

[0006] To achieve the above objectives, the technical solution of the present disclosure is implemented as follows:

[0007] A uterine cavity suction device comprises a hard suction tube and a hemostatic balloon assembly arranged on the hard suction tube;

[0008] A drainage cavity is formed in the rigid suction tube, and one end of the rigid suction tube is provided with a negative pressure drainage port communicating with the drainage cavity, the other end of the rigid suction tube is used to connect to a negative pressure source, and the end of the rigid suction tube away from the negative pressure drainage port is provided with a traction portion;

[0009] The hemostatic balloon assembly comprises a hemostatic balloon fixedly connected to the hard suction tube, and an injection channel connected to the hemostatic balloon. The hemostatic balloon is arranged close to the negative pressure drainage port, and the hemostatic balloon can be expanded after liquid is injected into the injection channel. The traction part is used to bear external force so that the expanded hemostatic balloon rests against the uterine wall.

[0010] Furthermore, the hard suction tube has a straight tube section and an inclined tube section, the straight tube section and the inclined tube section have a smooth transition, and the angle between the center lines of the straight tube section and the inclined tube section is between 10 and 15 degrees.

[0011] Furthermore, the straight pipe section (102) comprises a first straight pipe section (1021) and a second straight pipe section (1022), wherein the first straight pipe section (1021) is arranged close to the traction portion (3), and the outer diameter of the first straight pipe section (1021) is consistent with the inner diameter of the external negative pressure suction connecting pipe; the outer diameter of the second straight pipe section is between 11 mm and 20 mm, or the outer diameter of the second straight pipe section (1022) is between 5 mm and 10 mm.

[0012] Furthermore, when the outer diameters of the first straight pipe section (1021) and the second straight pipe section (1022) are different, the first straight pipe section (1021) and the second straight pipe section (1022) are connected together via a transition section (1023); the total length of the transition section (1023) and the first straight pipe section (1021) is between 38 mm and 42 mm.

[0013] Furthermore, the length of the straight pipe section (102) is between 30 cm and 35 cm; and the length of the inclined pipe section (103) is between 10 cm and 15 cm.

[0014] Furthermore, the negative pressure drainage port is provided on one side of the end portion of the hard suction tube.

[0015] Furthermore, the rigid suction tube is made of medical transparent plastic, and the material of the medical transparent plastic is any one of polyvinyl chloride, polypropylene, polystyrene and polycarbonate.

[0016] Furthermore, the length of the rigid suction tube is between 40-50 cm.

[0017] Furthermore, the thickness of the hemostatic balloon on a side close to the traction portion is greater than the thickness on a side close to the negative pressure drainage port.

[0018] Furthermore, the hemostatic balloon is made of any one of rubber, silicone and polyurethane materials.

[0019] Furthermore, the traction portion includes a protrusion fixedly connected to the hard suction tube, and the protrusion protrudes outward along the radial direction of the hard suction tube.

[0020] Furthermore, the raised portion (301) is cylindrical, and a limiting portion for limiting the external traction source from being disengaged is provided on the outer peripheral surface of the raised portion (301).

[0021] Furthermore, an injection tube is provided in the hard suction tube, the liquid inlet of the injection tube is located outside the hard suction tube, the liquid outlet of the injection tube is connected to the inside of the hemostatic balloon, and the lumen of the injection tube constitutes the injection channel.

[0022] Furthermore, an outer tube body is provided on the hard suction tube, and a liquid inlet is provided on the outer tube body. A cavity for liquid circulation is formed between the outer tube body and the hard suction tube. The cavity constitutes the injection channel, and one end of the cavity is connected to the interior of the hemostatic balloon, and the other end of the cavity is connected to the liquid inlet.

[0023] Compared with the prior art, the present disclosure has the following advantages:

[0024] The uterine suction device disclosed herein can be used for postpartum uterine bleeding caused by a variety of factors. A rigid suction tube with a negative pressure drainage port is placed in the postpartum uterus, with the external end connected to a negative pressure source. Blood, blood clots, and pregnancy residues in the uterus are first suctioned out to achieve the purpose of uterine curettage. The negative pressure during uterine curettage is controlled at 40-70 kPa. After uterine curettage, the negative pressure drops to 8-14 kPa. Continuous low-pressure suction ensures that active bleeding in the uterus is discharged in a timely manner, making it easier to observe the amount of bleeding. Simultaneously, the rigid suction tube is provided with a hemostatic balloon assembly. After the uterine curettage is completed, 200-1000 ml of liquid is injected into the hemostatic balloon through the injection channel to inflate it, achieving the effect of continuous compression to stop bleeding. In addition, due to the provision of a traction portion, it can be used to connect a weight to pull the hemostatic balloon, further strengthening the pressure on the lower uterine segment, thereby achieving rapid hemostasis.

[0025] Furthermore, by setting the angle between the straight and oblique tube sections between 10 and 15 degrees, the oblique tube section can be aligned with the longitudinal axis of the uterine cavity without adjusting the angle of the straight tube section, facilitating its entry into the uterine cavity. Furthermore, the rigid suction tube is constructed of medical-grade transparent plastic, which can be made from any of polyvinyl chloride, polypropylene, polystyrene, and polycarbonate. This rigid suction tube offers high strength and a low coefficient of friction, making it easy to insert and manipulate within the uterine cavity. Furthermore, it prevents deformation caused by the inflated hemostatic balloon.

[0026] In addition, the thickness of the hemostatic balloon on the side close to the traction part is greater than the thickness on the side close to the negative pressure drainage port. Since the thickened area is located at the lower end of the hemostatic balloon, the expansion is restricted at the lower end, and the lateral and upper expansion of the hemostatic balloon is facilitated, which is beneficial to accelerate the lateral expansion speed of the hemostatic balloon, thereby better compressing the lower part of the uterus. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] The accompanying drawings, which constitute part of this disclosure, are used to provide a further understanding of the disclosure. The exemplary embodiments of the disclosure and their descriptions are used to explain the disclosure and do not constitute an improper limitation of the disclosure. In the accompanying drawings:

[0028] FIG1 is a cross-sectional view of a uterine cavity suction device according to a first embodiment of the present disclosure;

[0029] FIG2 is a cross-sectional view taken along line AA of FIG1 ;

[0030] FIG3 is a schematic diagram of a first structural example of a traction unit according to an embodiment of the present disclosure;

[0031] FIG4 is a schematic diagram of a second structure of the traction part according to an embodiment of the present disclosure;

[0032] FIG5 is a cross-sectional view of the uterine cavity suction device according to the second embodiment of the present disclosure;

[0033] FIG6 is a cross-sectional view taken along line BB in FIG3 .

[0034] Description of reference numerals:

[0035] 1. Rigid suction tube;

[0036] 101, drainage cavity; 102, straight tube section; 103, oblique tube section; 104, injection tube; 105, outer tube body; 106, liquid inlet; 107, liquid outlet;

[0037] 1021, first straight pipe section; 1022, second straight pipe section; 1023, transition section;

[0038] 1031, negative pressure drainage port;

[0039] 1041, lumen;

[0040] 2. Hemostatic balloon assembly; 201. Hemostatic balloon; 202. Injection channel;

[0041] 3. Traction portion; 301. Raised portion; 3011. Groove; 3012. Mounting hole. DETAILED DESCRIPTION

[0042] It should be noted that, unless there is any conflict, the embodiments and features in the embodiments of the present disclosure may be combined with each other.

[0043] In the description of this disclosure, it should be noted that if terms such as "upper," "lower," "inner," and "outer" appear to indicate orientation or positional relationships, these are based on the orientation or positional relationships shown in the accompanying drawings and are intended solely to facilitate the description of this disclosure and simplify the description. They do not indicate or imply that the devices or components referred to must have a specific orientation, be constructed, or operate in a specific orientation. Therefore, they should not be construed as limitations on this disclosure. Furthermore, if terms such as "first" and "second" appear, they are used solely for descriptive purposes and should not be construed as indicating or implying relative importance.

[0044] Furthermore, in the description of this disclosure, unless otherwise explicitly defined, the terms "mounted," "connected," "connect," and "connector" should be interpreted broadly. For example, these terms can refer to fixed, removable, or integral connections; mechanical or electrical connections; direct or indirect connections through an intermediary; and internal communication between two components. Those skilled in the art will appreciate the specific meanings of these terms in this disclosure based on the specific circumstances.

[0045] The present disclosure will be described in detail below with reference to the accompanying drawings and in conjunction with embodiments. Example 1

[0046] Embodiments of the present disclosure relate to a uterine intraperitoneal suction device, comprising a rigid suction tube 1 and a hemostatic balloon assembly 2 mounted on the rigid suction tube 1. A drainage cavity 101 is formed within the rigid suction tube 1, and a negative pressure drainage port 1031 communicating with the drainage cavity 101 is provided at one end of the rigid suction tube 1. The other end of the rigid suction tube 1 is configured to connect to a negative pressure source, and a traction portion 3 is provided at the end of the rigid suction tube 1 remote from the negative pressure drainage port 1031.

[0047] Among them, the hemostatic balloon assembly 2 has a hemostatic balloon 201 fixedly connected to the hard suction tube 1, and an injection channel 202 connected to the hemostatic balloon 201. The hemostatic balloon 201 is arranged close to the negative pressure drainage port 1031, and the hemostatic balloon 201 can be expanded after liquid is injected into it through the injection channel 202. The traction part 3 is used to bear external force to make the expanded hemostatic balloon 201 press against the uterine wall.

[0048] The disclosed intrauterine suction device achieves effective uterine curettage by placing a rigid suction tube 1 with a negative pressure drainage port 1031 within the postpartum uterus. The negative pressure source draws blood, blood clots, and pregnancy remnants from the uterus through the drainage cavity 101, thereby extracting them. A hemostatic balloon assembly 2 is also provided. Liquid is injected into the hemostatic balloon 201 through an injection channel 202, causing it to expand and compress the uterine wall to achieve hemostasis. A traction portion 3 can be connected to a weight to ensure that the hemostatic balloon 201 continuously applies pressure to the lower part of the uterus, thereby achieving rapid hemostasis.

[0049] Based on the above overall introduction, an exemplary structure of the intrauterine suction device disclosed in the present invention is shown in Figure 1. The drainage cavity 101 of this embodiment is arranged along the length direction of the hard suction tube 1, and the negative pressure drainage port 1031 is arranged at one end of the hard suction tube 1 deep into the uterus. The other end of the hard suction tube 1 is provided with a traction part 3 arranged perpendicular to its own length direction on the outside.

[0050] In the early stage of use, the hemostatic balloon 201 is not filled with liquid. Medical personnel place the intrauterine suction device into the uterine cavity. Since the hemostatic balloon 201 is arranged on the rigid suction tube 1, the hemostatic balloon 201 enters the uterine cavity together with the rigid suction tube 1. The depth of the rigid suction tube 1 in the uterine cavity is determined according to the size of the uterus. The blood, blood clots, residual placenta and fetal membranes in the uterus are sucked out by the negative pressure source. Then, physiological saline or other intravenous injection liquid is injected into the hemostatic balloon 201 through the injection channel 202, causing the hemostatic balloon 201 to expand and compress the inner wall of the uterine cavity. After the hemostatic balloon is fully expanded, the rigid suction tube 1 is pulled outward with force, so that the hemostatic balloon 201 can effectively compress the lower part of the uterine cavity, thereby achieving the purpose of rapid hemostasis.

[0051] As a preferred embodiment, the rigid suction tube 1 of this embodiment is made of a transparent medical rigid plastic, selected from polyvinyl chloride, polypropylene, polystyrene, and polycarbonate. The rigid suction tube 1 has high strength and a low coefficient of friction, making it easy to insert and operate within the uterine cavity. The rigid suction tube 1 maintains unobstructed drainage lumen 101, allowing for rapid removal of blood, blood clots, and pregnancy residues from the uterine cavity. It also ensures unobstructed access to the injection channel 202, allowing the hemostatic balloon 201 to rapidly inflate.

[0052] Furthermore, to better accommodate the anatomical structures of the pelvis, uterus, and vagina, the rigid suction tube 1 comprises a straight section 102 and an oblique section 103. The straight and oblique sections 102 and 103 have a smooth transition, and the centerline angle between the straight and oblique sections 102 and 103 is between 10 and 15 degrees, facilitating uterine cavity cleaning. Specifically, as shown in Figures 2 and 6 , the section near the negative pressure drainage port 1031 is the oblique section 103. The traction unit 3 is connected to the side of the straight section 102 away from the oblique section 103. When the intrauterine suction device is in use, portions of the straight section 102 and the traction unit 3 are exposed outside the vagina.

[0053] As shown in Figures 1 and 5, the length L of the hard suction tube 1 of this embodiment is between 40cm and 50cm. In specific implementation, it can be set to sizes such as 40cm, 45cm, and 50cm, and the length L of the hard suction tube 1 is preferably set to 45cm.

[0054] In this embodiment, as the first structural form, the hard suction tube 1 has an overall structure in which the straight pipe section 102 includes a first straight pipe section 1021 and a second straight pipe section 1022. The first straight pipe section 1021 is the end of the hard suction tube 1 close to the traction part 3, wherein the outer diameter of the first straight pipe section 1021 is consistent with the inner diameter of the external negative pressure suction connecting pipe, so that the first straight pipe section 1021 can be directly connected to the external negative pressure suction connecting pipe, avoiding the use of docking parts and simplifying assembly.

[0055] The outer diameter D of the second straight pipe section 1022 is between 11 mm and 20 mm. In specific implementation, it can be set to 11 mm, 12 mm, 13 mm, 14 mm, 15 mm, 16 mm, 17 mm, 18 mm, 19 mm or 20 mm, and preferably, the inner diameter of the second straight pipe section 1022 is 15 mm, and the length of the second straight pipe section is preferably 220 mm.

[0056] In this embodiment, as a second structural form, the rigid suction tube 1, in its overall structure, has a straight tube section 102 comprising a first straight tube section 1021 and a second straight tube section 1022. The outer diameter of the first straight tube section 1021 also matches the inner diameter of the external negative pressure suction connection tube. However, the outer diameter D of the second straight tube section 1022 is between 5 mm and 10 mm. In practice, the outer diameter of the second straight tube section 1022 can be, for example, 5 mm, 6 mm, 7 mm, 8 mm, 9 mm, or 10 mm.

[0057] It should be noted that in the rigid suction tube 1 of the above structure, the second straight tube section 1022 having an outer diameter D between 11 mm and 20 mm is suitable for post-vaginal bleeding or bleeding after a cesarean section. The second straight tube section 1022 having an outer diameter D between 5 mm and 10 mm is suitable for post-selective cesarean section bleeding without cervical dilation.

[0058] In this embodiment, when the outer diameters of the first straight tube section 1021 and the second straight tube section 1022 differ, the first straight tube section 1021 and the second straight tube section 1022 are connected together via a transition section 1023. The total length of the transition section 1023 and the first straight tube section 1021 is between 38 mm and 42 mm, preferably 40 mm, but may also be 38 mm, 39 mm, 41 mm, or 42 mm. This arrangement enhances the negative pressure effect of the negative pressure drainage port 1031, facilitating the absorption of blood clots, blood, and pregnancy residues.

[0059] Preferably, the rigid suction tube 1 of this embodiment is integrally formed by injection molding. During operation, the end of the straight tube section 102 is connected to an external negative pressure suction device, and blood and pregnancy residues removed from the uterine cavity flow into a container connected to the negative pressure suction system, making it easier to monitor the amount of bleeding.

[0060] In the initial stage of use, the oblique tube section 103 is inserted into the vagina and into the uterine cavity, negative pressure suction is connected, and the straight tube section 102 is manually rotated. The oblique tube section 103 then rotates in the uterine cavity to remove blood clots or blood in the uterine cavity. If necessary, the straight tube section 102 can be repeatedly pulled out and inserted to completely suck out the substances in the uterine cavity.

[0061] Furthermore, the angle between the straight tube section 102 and the oblique tube section 103 is set between 10 and 15 degrees. This arrangement allows the oblique tube section 103 to be aligned with the longitudinal axis of the uterine cavity without adjusting the angle of the straight tube section 102, making it easier for the oblique tube section 103 to enter the uterine cavity and remove the contents of the uterine cavity.

[0062] Furthermore, as a preferred embodiment, the length of the oblique tube section 103 is preferably set between 10cm-15cm, the length of the oblique tube section 103 exposed outside the hemostatic balloon 201 is preferably set between 3cm-5cm, and the length of the straight tube section 102 is between 30cm-35cm.

[0063] Furthermore, the negative pressure drainage port 1031 of this embodiment is located on the sidewall near one end of the rigid suction tube 1. Specifically, as shown in Figures 2 and 6 , the negative pressure drainage port 1031 is formed at the end of the oblique tube section 103. Its longitudinal cross-section is a concave arc that is recessed into the oblique tube section 103, with its opening facing the tube wall of the oblique tube section 103, forming an elliptical shape. Placing the negative pressure drainage port 1031 on the sidewall prevents blockage of the drainage lumen 101 caused by the end of the rigid suction tube 1 abutting against the inner wall of the cervix during drainage, thereby improving the performance of the rigid suction tube 1.

[0064] Furthermore, the sharp corners of the head of the negative pressure drainage port 1031 are smoothly rounded to prevent the sharp corners from damaging the uterus. Furthermore, the edges of the negative pressure drainage port 1031 of the rigid suction tube 1 also need to be rounded to prevent the sharp corners of the rigid suction tube 1 from touching the inner wall of the cervix during rotation and causing damage.

[0065] Furthermore, as shown in Figure 1, the length L of the rigid suction tube 1 of this embodiment is between 40cm and 50cm, preferably, for example, 40cm, 45cm, or 50cm. When treating bleeding after vaginal delivery, such as bleeding after vaginal delivery or bleeding after a cesarean section, a rigid suction tube 1 with an outer diameter D between 11mm and 20mm is selected. For bleeding after an elective cesarean section without cervical dilation, a rigid suction tube 1 with an outer diameter D between 5mm and 10mm is selected.

[0066] As a preferred embodiment, the hemostatic balloon 201 in this embodiment is made of any of rubber, silicone, and polyurethane materials. Alternatively, materials such as polyvinyl chloride, polyethylene, nylon, or other expandable elastomers and polymers may be used. Preferably, the material of the hemostatic balloon 201 has good compliance, allowing for easy filling and expansion of liquid. The expanded shape should conform to the uterine and pelvic cavities, achieving the purpose of packing and compressing hemostasis.

[0067] As shown in FIG1 and FIG2 and FIG5 and FIG6, the hemostatic balloon 201 of this embodiment is formed into an elliptical sphere, so that the hemostatic balloon 201 can be pressed against the uterine wall after being filled, thereby applying pressure to the uterine cavity to control bleeding.

[0068] Furthermore, the inflated hemostatic balloon 201 has a long axis dimension between 8cm and 12cm, and a short axis dimension between 6cm and 10cm. More importantly, the balloon's high compliance facilitates shape changes. Because the postpartum uterine cavity is irregular and constantly changing, a balloon with an easily adaptable shape is more conducive to maintaining pressure on the uterine wall.

[0069] The hemostatic balloon 201 of this embodiment can be injected with any liquid used for intravenous infusion, such as normal saline, compound sodium chloride injection or 5% glucose solution, etc. The amount of injected liquid depends on the size of the uterine cavity and is usually between 200 ml and 1000 ml.

[0070] The retention time of the inflated hemostatic balloon 201 in the uterine cavity is determined by the condition of postpartum hemorrhage, usually between 1 and 72 hours. If no obvious bleeding is observed in the vacuum suction tube, the liquid in the balloon can be emptied and the entire uterine cavity suction device can be removed.

[0071] The thickness of the hemostatic balloon 201 of this embodiment is greater on the side near the traction portion 3 than on the side near the negative pressure drainage port 1031. As shown in Figures 1 and 2 and Figures 5 and 6, the upper and lower ends of the hemostatic balloon 201 have different wall thicknesses. Because the pulling of the traction portion 3 causes deformation of the hemostatic balloon 201, the hemostatic balloon 201 at the thicker wall becomes less expandable, and the hemostatic balloon 201 is guided to an area with a thinner wall or greater expandability.

[0072] The wall thickness of the hemostatic balloon 201 is determined by the selected material. For example, the lower end wall thickness can be set between 0.04mm and 0.08mm, or the spacing between the lower and upper end wall thicknesses can be set between 0.02mm and 0.04mm. In this embodiment, the thickened region is located at the lower portion of the hemostatic balloon 201, limiting expansion at the lower portion. This facilitates lateral and upward expansion of the hemostatic balloon 201, accelerating its lateral expansion rate. Furthermore, the lower portion of the hemostatic balloon 201 can effectively compress the lower portion of the uterus, achieving a better hemostatic effect.

[0073] In other embodiments, the outer surface of the hemostatic balloon 201 can be coated with hemostatic materials or drugs in the form of a layer of film, spray, gel or powder, so that the hemostatic material or drugs on the balloon surface can contact the inner wall tissue of the uterine cavity to further enhance the hemostatic effect.

[0074] In addition, the traction portion 3 is used for external force pulling. The traction portion 3 can be molded at one time when the rigid suction tube 1 is injection molded, or the structure for traction can be attached to the rigid suction tube 1. The shape of the traction portion 3 can be expressed in various forms, including raised columns, hooks, and rings. This embodiment is illustrated with a raised column. The raised portion 301 protrudes outward along the radial direction of the rigid suction tube 1. In terms of specific structure, as shown in Figures 1, 3, 4 and 5, the raised portion 301 of this embodiment is connected to the outer wall of the rigid suction tube 1, and the two oppositely arranged raised portions 301 are protruding outward perpendicular to the axis of the rigid suction tube 1.

[0075] Still as shown in Figures 1, 3, 4 and 5, the protrusion 301 is cylindrical so as to facilitate connection with an external traction source via the protrusion 301. The external traction source can be any method of applying traction, such as manually pulling, hooking a weight or a filled IV bag / bottle, or tying a traction line to an external fixture.

[0076] The traction of the traction part 3 and the external traction source can increase the pressure of the hemostatic balloon 201 on the lower uterine segment and cervix, and also compress the pelvic blood vessels supplying the uterus, including the uterine artery, to achieve the purpose of quickly controlling bleeding.

[0077] In this embodiment, to enhance the securing effect of the external traction source on the raised portion 301, as shown in FIG3 , a limiting portion is also provided on the outer circumferential surface of the cylindrical raised portion 301 to prevent the external traction source from being detached. Specifically, the limiting portion is a mounting hole 3012 provided on the outer circumferential surface of each cylindrical raised portion 301, with the axial direction of each mounting hole 301 being orthogonal to the axial direction of the raised portion 301. Furthermore, during actual use, the connecting ends of the external traction source are sequentially inserted into the two mounting holes. The connecting ends may be, for example, a traction line or a traction hose. This effectively prevents the external traction source from detaching from the raised portion 301, and effectively prevents the external traction source from detaching from the raised portion 301, thereby ensuring the securing effect of the external traction source.

[0078] Of course, it is understood that the retaining portion of this embodiment can also adopt the structure shown in Figure 4 in addition to the structure shown in Figure 3. As shown in Figure 4, the retaining portion is specifically a groove arranged circumferentially around the raised portion 301, and the grooves are preferably arranged at both ends of the raised portion 301 to enhance the stability of the hook. During actual use, the connecting end of the external traction source can be locked into the groove. This can also effectively prevent the external traction source from detaching from the raised portion 301, effectively preventing the external traction source from detaching from the raised portion 301, and ensuring the external traction source is effectively fixed.

[0079] It should be noted that, in addition to being a groove disposed circumferentially around the raised portion 301, the limiting portion can also be configured as a raised ring disposed circumferentially around the raised portion 301. For example, a plurality of raised rings can be provided, arranged at intervals, and the plurality of raised rings are preferably disposed at both ends of the raised portion 301. During actual use, the connection end of the external traction source can be clamped between two adjacent raised rings. This prevents the external traction source from being detached from the raised portion 301 and improves the stability of the external traction source's attachment.

[0080] The external traction source for the traction part 3 in this embodiment can be a water bag with a weight between 500kg and 1000kg. Of course, the pulling force can also be achieved by tying the rope with an external fixed object.

[0081] In addition, in this embodiment, a packing is provided in the vagina. The packing may be a gauze block or a gauze strip, and the gauze block or gauze strip may contain various hemostatic and anti-infective drugs. The vaginal packing is positioned around the rigid suction tube 1, filling the entire vagina and preventing the hemostatic balloon 201 and the rigid suction tube 1 from being dislodged from the uterine cavity. The lower end of the packing is exposed at the vaginal opening. The provision of the packing can provide a certain resistance to the traction force of the traction portion 3 and stabilize the position of the hemostatic balloon 201 in the uterine cavity. After the hemostasis operation is completed, the packing can be pulled out of the vagina, facilitating the removal of the rigid suction tube 1 from the body.

[0082] Furthermore, as a preferred embodiment, a hemostatic agent such as oxidized cellulose, thrombin, and other coagulation factors may be added to the packing before packing, which can further improve the hemostatic effect of the packing.

[0083] Furthermore, to enhance the effectiveness of use, the rigid suction tube 1 of this embodiment is provided with an injection tube 104. The liquid inlet 106 of the injection tube 104 is located on the outside of the rigid suction tube 1, and the liquid outlet 107 of the injection tube 104 communicates with the interior of the hemostatic balloon 201. The lumen 1041 of the injection tube 104 forms an injection channel 202. Specifically, as shown in Figures 1 and 2, the rigid suction tube 1 is provided with a channel for the injection tube 104 to flow in. The injection tube 104 of this embodiment can be made of a flexible conduit, such as polyethylene, silicone resin, polyurethane, or nylon.

[0084] As shown in Figures 1 and 2, the injection tube 104 passes from the outside of the rigid suction tube 1 into the drainage lumen 101 within the tube, and then passes through the rigid suction tube 1 again in the middle of the hemostatic balloon 201, extending the liquid outlet 107 of the injection tube 104 into the hemostatic balloon 201. This embodiment uses a single injection tube 104, but multiple injection tubes 104 can also be used to increase the injection speed of the hemostatic balloon 201.

[0085] Furthermore, the diameter of the lumen 1041 of the injection tube 104 can be adaptively adjusted according to the injection volume. The hemostatic balloon 201 inflates in approximately 2 minutes or less, and most preferably in 1 minute or less. Furthermore, the injection port of the injection tube 104 is connected to an external infusion pump or other fluid container, which can hold or supply physiological fluids or other intravenous fluids.

[0086] The method for using the uterine cavity suction device disclosed herein comprises the following steps:

[0087] First, when postpartum uterine bleeding occurs, medical staff gently insert the rigid suction tube 1 and the unfilled hemostatic balloon 201 into the uterine cavity through the vagina and cervix. The external end of the rigid suction tube 1 is connected to a negative pressure source. Blood, blood clots, and pregnancy residues in the uterus are first suctioned out to achieve the purpose of uterine curettage. The negative pressure during uterine curettage is controlled at 40-70 kPa. After uterine curettage, negative pressure suction can be continued, but the negative pressure is reduced to 8-14 kPa. Continuous low-pressure suction is conducive to the timely discharge of intrauterine bleeding and keeps the uterus in a contracted state.

[0088] Then, a syringe or an infusion pump is used to inject physiological saline into the injection tube 104, and the expanded hemostatic balloon 201 is pressed against the inner wall of the uterine cavity to achieve a hemostatic effect. Example 2

[0089] The embodiment of the present disclosure also relates to a uterine cavity suction device, which has the hard suction tube 1 and the hemostatic balloon 201 in the first embodiment. The difference from the first embodiment is that the method of outputting liquid to the hemostatic balloon 201 is different.

[0090] As a preferred embodiment, as shown in Figures 5 and 6 , the rigid suction tube 1 of this embodiment is sheathed with an outer tubular body 105, which is provided with a liquid inlet 106. A cavity for liquid circulation is formed between the outer tubular body 105 and the rigid suction tube 1. This cavity constitutes the aforementioned liquid injection channel 202. One end of the cavity communicates with the interior of the hemostatic balloon 201, and the other end of the cavity communicates with the liquid inlet 106.

[0091] Structurally, as shown in Figures 5 and 6 , the end of the outer tube 105 proximal to the traction portion 3 is fixedly connected to the outer wall of the rigid suction tube 1 , either by bonding or by integrally molding with the rigid suction tube 1 . Preferably, the outer tube 105 is contoured to the rigid suction tube 1 , and the inner diameter of the outer tube 105 is larger than the outer diameter of the rigid suction tube 1 , forming the aforementioned injection channel 202 therebetween.

[0092] A liquid inlet 106 is radially arranged on the outer wall of the outer tube 105. The liquid inlet 106 is connected to the liquid injection channel 202. The liquid inlet 106 is connected to an external liquid injection pump, and the liquid flows into the hemostatic balloon 201 through the liquid injection channel 202. Of course, the number of liquid inlets 106 can also be adaptively adjusted according to the required inflation time of the hemostatic balloon 201.

[0093] The steps for using the uterine cavity suction device of this embodiment are the same as those described in Example 1, and will not be repeated here.

[0094] The above description is only a preferred embodiment of the present disclosure and is not intended to limit the present disclosure. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present disclosure should be included in the scope of protection of the present disclosure.

Claims

1. A uterine cavity suction device, characterized in that: It comprises a hard suction tube (1), and a hemostatic balloon assembly (2) arranged on the hard suction tube (1); A drainage cavity (101) is formed in the rigid suction tube (1), and one end of the rigid suction tube (1) is provided with a negative pressure drainage port (1031) in communication with the drainage cavity (101); the other end of the rigid suction tube (1) is used for connecting to a negative pressure source, and the end of the rigid suction tube (1) away from the negative pressure drainage port (1031) is provided with a traction portion (3); The hemostatic balloon assembly (2) comprises a hemostatic balloon (201) fixedly connected to the hard suction tube (1), and an injection channel (202) connected to the hemostatic balloon (201); the hemostatic balloon (201) is arranged close to the negative pressure drainage port (1031), and the hemostatic balloon (201) can expand after liquid is injected through the injection channel (202); the traction part (3) is used to bear external force so that the expanded hemostatic balloon (201) is pressed against the uterine wall.

2. The intrauterine suction device according to claim 1, characterized in that: The hard suction tube (1) comprises a straight tube section (102) and an inclined tube section (103); the straight tube section (102) and the inclined tube section (103) have a smooth transition, and the centerline angle between the straight tube section (102) and the inclined tube section (103) is between 10 and 15 degrees.

3. The intrauterine suction device according to claim 2, characterized in that: The straight pipe section (102) comprises a first straight pipe section (1021) and a second straight pipe section (1022); the first straight pipe section (1021) is arranged close to the traction portion (3); and the outer diameter of the first straight pipe section (1021) is consistent with the inner diameter of the external negative pressure suction connecting pipe; The outer diameter of the second straight pipe section (1022) is between 11 mm and 20 mm, or the outer diameter of the second straight pipe section (1022) is between 5 mm and 10 mm.

4. The intrauterine suction device according to claim 3, characterized in that: When the outer diameters of the first straight pipe section (1021) and the second straight pipe section (1022) are different, the first straight pipe section (1021) and the second straight pipe section (1022) are connected together via a transition section (1023); The total length of the transition section (1023) and the first straight pipe section (1021) is between 38 mm and 42 mm.

5. The intrauterine suction device according to claim 2, characterized in that: The length of the straight pipe section (102) is between 30 cm and 35 cm; The length of the inclined tube section (103) is between 10 cm and 15 cm.

6. The intrauterine suction device according to claim 1, characterized in that: The negative pressure drainage port (1031) is arranged on one side of the end of the hard suction tube (1).

7. The intrauterine suction device according to claim 1, characterized in that: The hard suction tube (1) is made of medical transparent plastic, and the material of the medical transparent plastic is any one of polyvinyl chloride, polypropylene, polystyrene and polycarbonate.

8. The intrauterine suction device according to claim 1, characterized in that: The length of the rigid suction tube (1) is between 40 cm and 50 cm.

9. The intrauterine suction device according to claim 1, characterized in that: The thickness of the hemostatic balloon (201) on the side close to the traction portion (3) is greater than the thickness on the side close to the negative pressure drainage port (1031).

10. The intrauterine suction device according to claim 1, characterized in that: The hemostatic balloon (201) is made of any one of rubber, silicone and polyurethane materials.

11. The intrauterine suction device according to claim 1, characterized in that: The traction portion (3) comprises a protrusion (301) fixedly connected to the hard suction tube (1), and the protrusion (301) protrudes outward in the radial direction of the hard suction tube (1).

12. The intrauterine suction device according to claim 11, characterized in that: The raised portion (301) is cylindrical, and a limiting portion for limiting the external traction source from being disengaged from the hook is provided on the outer peripheral surface of the raised portion (301).

13. The intrauterine suction device according to any one of claims 1 to 12, characterized in that: An injection tube (104) is provided inside the rigid suction tube (1); a liquid inlet (106) of the injection tube (104) is located outside the rigid suction tube (1); a liquid outlet (107) of the injection tube (104) is connected to the interior of the hemostatic balloon (201); and a lumen (1041) of the injection tube (104) constitutes the injection channel (202).

14. The intrauterine suction device according to any one of claims 1 to 12, characterized in that: The hard suction tube (1) is sleeved with an outer tube body (105), and the outer tube body (105) is provided with a liquid inlet (106); A cavity for the liquid to circulate is formed between the outer tube body (105) and the hard suction tube (1), the cavity constituting the injection channel (202), one end of the cavity being connected to the interior of the hemostatic balloon (201), and the other end of the cavity being connected to the liquid inlet (106).

Citation Information

Patent Citations

  • Uterine cavity compression hemostatic balloon catheter and control system thereof

    CN109620335A

  • Negative pressure uterine cavity packing hemostasis device

    CN112494094A

  • Medical negative pressure formula cleaning device

    CN208319605U

  • Uterus operation is with uterus device that stanchs

    CN208551907U

  • Pelvic cavity compression hemostasis bag

    CN216021222U